No Data
ACESO LIFE SCI: Interim Report 2024/25
Aceso Life Sci (00474.HK): Jiang Yang appointed as a non-executive director.
Gelonghui, December 3rd丨aceso life sci (00474.HK) announced that Jiang Yang has been appointed as a non-executive director of the company, effective from December 3, 2024.
Aceso Life Science's Fiscal H1 Loss Narrows
Aceso life sci (00474.HK) has a mid-term loss of approximately 0.195 billion HKD.
Glory Financial reported on November 28 that aceso life sci (00474.HK) announced that for the six months ended September 30, 2024, the company's total revenue was approximately 109 million HKD (2023: approximately 113 million HKD). During this period, the group incurred a loss of approximately 195 million HKD (2023: 250 million HKD).
ACESO LIFE SCI: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Aceso life sci (00474.HK) will hold a board of directors meeting on November 28 to approve the interim performance.
Gelonghui, November 18丨aceso life sci (00474.HK) announced that the board of directors meeting will be held on Thursday, November 28, 2024, at 12:00 noon at Room 2501-2509, 25th Floor,瑞安中心, 6-8 Harbor Road, Wan Chai, Hong Kong, to (including) approve the company's and its subsidiaries' unverified interim results for the six months ending September 30, 2024, and its publication, as well as to consider the distribution of an interim dividend (if any).
